2005 Annual Meeting | Neurological Complications of Medical Disease

Date Thursday 04/14/05

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Douglas J. Gelb, MD, PhD, FAAN

Topic(s) General Neurology/Neurology of Systemic Disease

Learning Objectives Upon completion:
Participants should be able to understand the practical challenges involved in the diagnosis and management of patients with neurological disorders in the setting of gastrointestinal disease, heavy metal disorders, and sarcoidosis. Participants should also know the neurological benefits and risks of statin use.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
02:15 PM - 02:25 PM		Introduction
02:25 PM - 03:15 PM		Statins: How They Can Help, How They Can Hurt Susan L. Hickenbottom, MD
03:15 PM - 04:05 PM		Heavy Metal Disorders Neeraj Kumar, MD
04:05 PM - 04:20 PM		Break
04:20 PM - 05:10 PM		Sarcoidosis Barney J. Stern, MD, FAAN
05:10 PM - 06:00 PM		Gastointestinal Disease Mark B. Skeen, MD, FAAN

Faculty Disclosures
Barney J. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Foundation for Sarcoidosis Research. The institution of Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. The institution of Dr. Stern has received research support from NIH/NINDS. Dr. Stern has received publishing royalties from a publication relating to health care.
Susan L. Hickenbottom, MD	No disclosure on file
Neeraj Kumar, MD	Dr. Kumar has nothing to disclose.
Mark B. Skeen, MD, FAAN	Dr. Skeen has received personal compensation for serving as an employee of VeraSci. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD/Serono. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squib. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD/ Serono. The institution of Dr. Skeen has received research support from National MS Society. Dr. Skeen has received personal compensation in the range of $50,000-$99,999 for serving as a Retiree with US Navy.
Douglas J. Gelb, MD, PhD, FAAN	Dr. Gelb has received publishing royalties from a publication relating to health care. Dr. Gelb has received publishing royalties from a publication relating to health care. Dr. Gelb has received publishing royalties from a publication relating to health care. Dr. Gelb has received personal compensation in the range of $500-$4,999 for serving as a multiple choice question writer for Continuum with AAN.

��ɫ��

��ɫ��